Pre-PCI C-reactive protein–triglyceride glucose index and angiographic no-reflow or slow flow in acute myocardial infarction: a single-centre retrospective study
This single-center retrospective study of 429 acute myocardial infarction patients demonstrates that a higher pre-procedural C-reactive protein–triglyceride glucose index (CTI) is independently and nonlinearly associated with an increased risk of angiographic no-reflow or slow flow following percutaneous coronary intervention, providing significant incremental predictive value beyond routine clinical variables.
Original paper licensed under CC BY 4.0 (https://creativecommons.org/licenses/by/4.0/). This is an AI-generated explanation of the paper below. It is not written or endorsed by the authors. For technical accuracy, refer to the original paper. Read full disclaimer
When a heart attack strikes, time is tissue. The standard emergency response is to rush a patient to a catheterization lab, where a doctor threads a thin tube through the blood vessels to the blocked artery and inflates a tiny balloon to push the clot aside. This procedure, known as percutaneous coronary intervention, is designed to restore the flow of oxygen-rich blood to the starving heart muscle. However, a frustrating and dangerous complication can occur even after the main highway is cleared. Sometimes, the tiny capillaries downstream remain clogged or paralyzed, preventing blood from actually reaching the heart cells. In medical terms, this is called "no-reflow" or "slow flow." It is as if a city's main road has been cleared of a landslide, but the side streets remain blocked, leaving the neighborhoods in darkness. This failure of microcirculation leads to larger heart damage and worse outcomes for the patient, yet doctors currently have few reliable ways to predict who will face this problem before they even begin the procedure.
Researchers at Zhengzhou Central Hospital in China set out to find a better way to spot these high-risk patients. They focused on a specific combination of two biological signals that are already measured in almost every hospital: inflammation and metabolic health. Inflammation is the body's natural response to injury, often marked by a protein called C-reactive protein, which rises when the body is under stress or fighting damage. Metabolic health, specifically how well the body handles sugar and fat, is often gauged by a calculation involving triglycerides and glucose. The team combined these two distinct pieces of information into a single score, which they call the C-reactive protein–triglyceride glucose index. The idea was that a patient with high levels of both inflammation and metabolic strain might have blood vessels that are more fragile and prone to collapsing after the stress of opening a blocked artery.
To test this idea, the researchers looked back at the records of 429 patients who had suffered a heart attack and undergone this emergency procedure between January 2023 and January 2025. Before the doctors started the procedure, they collected blood samples to calculate this combined score for every patient. After the procedure, two experienced heart specialists, who did not know the patients' scores, reviewed the angiograms to see if blood flow had returned to normal or if it remained sluggish. They found that 102 of the patients experienced this no-reflow or slow-flow complication. When the team compared the groups, a clear pattern emerged: the patients who suffered from poor blood flow had significantly higher scores on this combined index before the procedure started. Their average score was about 10.57, compared to 9.39 for those whose blood flow returned normally.
The study suggests that this single number carries significant weight. Even after the researchers accounted for other known risk factors like age, sex, diabetes, high blood pressure, smoking, and kidney function, the score remained a powerful predictor. The data indicated that for every single point increase in this score, the odds of experiencing poor blood flow after the procedure jumped dramatically. The relationship was not a simple straight line; the risk seemed to rise more sharply as the score got higher, suggesting that the danger escalates quickly once a certain threshold is crossed. When the researchers added this score to a standard model used to predict risk, the model became much better at distinguishing between patients who would have a smooth recovery and those who would face complications. The ability of the model to correctly identify the at-risk group improved noticeably, moving from a score of 0.850 to 0.889, a statistically meaningful gain.
The researchers also checked whether this score worked differently for people with diabetes, a condition often linked to both inflammation and metabolic issues. They found that the score predicted risk just as well for patients with diabetes as it did for those without, meaning the index is a useful tool across different patient groups. However, the authors are careful to note that this was a single-center study looking at past records, and the findings are not yet a final rule for clinical practice. The specific number that might serve as a warning threshold, and how this score should be used to change treatment plans, requires further testing in larger, diverse groups of patients. For now, the study offers a compelling new lens through which to view the heart attack patient: a simple blood test taken before the procedure can reveal a hidden vulnerability in the tiny vessels that might otherwise go unnoticed until it is too late.
Drowning in papers in your field?
Get daily digests of the most novel papers matching your research keywords — with technical summaries, in your language.